|
注册号: Registration number: |
ChiCTR2500098729 |
|
最近更新日期: Date of Last Refreshed on: |
2025-03-13 08:29:34 |
|
注册时间: Date of Registration: |
2025-03-13 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
气管导管和喉罩置入术后咽部疼痛的发生率及相关因素的临床观察性研究 |
|
Public title: |
Clinical observation of the incidence and related factors of pharyngeal pain after tracheal catheter and laryngeal mask insertion |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
气管导管和喉罩置入术后咽部疼痛的发生率及相关因素的临床观察性研究 |
|
Scientific title: |
Clinical observation of the incidence and related factors of pharyngeal pain after tracheal catheter and laryngeal mask insertion |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
蔡丽 |
研究负责人: |
王长明 |
|
Applicant: |
Cai Li |
Study leader: |
Wang Changming |
|
申请注册联系人电话: Applicant telephone: |
+86 156 4237 7573 |
研究负责人电话:
Study leader's |
+86 177 0248 6100 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1181424687@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
TeamWangCM@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
辽宁省沈阳市沈河区文艺路33号 |
研究负责人通讯地址: |
辽宁省沈阳市沈河区文艺路33号 |
|
Applicant address: |
33 Wenyi Road, Shenhe District, Shenyang City, Liaoning Province |
Study leader's address: |
33 Wenyi Road, Shenhe District, Shenyang City, Liaoning Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
辽宁省人民医院 |
||
|
Applicant's institution: |
Liaoning Provincial People‘s Hospital |
||
|
研究负责人所在单位: |
辽宁省人民医院 |
||
|
Affiliation of the Leader: |
Liaoning Provincial People‘s Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2025)H024号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
辽宁省人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics committee of Liaoning Provincial People’s Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-02-27 00:00:00 | ||
|
伦理委员会联系人: |
郑凯 |
||
|
Contact Name of the ethic committee: |
Zheng Kai |
||
|
伦理委员会联系地址: |
辽宁省沈阳市沈河区文艺路33号 |
||
|
Contact Address of the ethic committee: |
33 Wenyi Road, Shenhe District, Shenyang, Liaoning |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24016355 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
辽宁省人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Liaoning Provincial People‘s Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省沈阳市沈河区文艺路33号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
33 Wenyi Road,Shenhe District,Shenyang,Liaoning |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||
|
研究疾病: |
术后咽喉痛 |
||||||||||||||||||||||
|
Target disease: |
Postoperative sore throat |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
对比全麻下进行气管插管或喉罩的术后并发症的发生率,严重程度,探讨影响术后呼吸道并发症的相关因素,探讨如何减少相关因素的组合,降低POST的发生率、严重程度,以探求全身麻醉下行气道管理操作的优化方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
The incidence and severity of postoperative complications of tracheal intubation or laryngeal mask under general anesthesia were compared, the related factors affecting postoperative respiratory complications were discussed, and how to reduce the combination of related factors to reduce the incidence and severity of POST was discussed, so as to explore the optimal program of airway management operation under general anesthesia. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.手术在颈部、口腔或咽喉部区域。 2.近期或正在进行的上呼吸道感染。 3.经鼻气管插管或双腔气管插管。 4.存在术前咽喉痛患者。 5.手术时间大于4h。 6.无完全民事行为能力者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Surgery in the neck mouth or throat area. 2.A recent or ongoing upper airway infection. 3.Nasal intubation or double-chamber tracheal intubation. 4.Patients with preoperative sore throat. 5.Expected duration of surgery >240 minutes. 6.Individuals who are unwilling or unable to communicate. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-03-15 00:00:00至 To 2026-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-03-15 00:00:00 至 To 2025-09-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结束后,中国临床试验注册中心(www.chictr.org.cn) |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the end of the study,China clinical trial registration center(www.chictr.org.cn) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
ResMan |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
ResMan |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |